Cargando…
Hierarchically porous, and Cu- and Zn-containing γ-AlOOH mesostrands as adjuvants for cancer immunotherapy
Alum is the only licensed adjuvant by Food and Drug Administration of USA used in many human vaccines and has excellent safety record in clinical applications. However, alum hardly induces T helper 1 (Th1) immune responses that are required for anti-tumor immunity. In the present study, we fabricate...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711866/ https://www.ncbi.nlm.nih.gov/pubmed/29196724 http://dx.doi.org/10.1038/s41598-017-12446-9 |
_version_ | 1783283104274710528 |
---|---|
author | Li, Xia Shenashen, Mohamed A. Wang, Xiupeng Ito, Atsuo Taniguchi, Akiyoshi EI-Safty, Sherif A. |
author_facet | Li, Xia Shenashen, Mohamed A. Wang, Xiupeng Ito, Atsuo Taniguchi, Akiyoshi EI-Safty, Sherif A. |
author_sort | Li, Xia |
collection | PubMed |
description | Alum is the only licensed adjuvant by Food and Drug Administration of USA used in many human vaccines and has excellent safety record in clinical applications. However, alum hardly induces T helper 1 (Th1) immune responses that are required for anti-tumor immunity. In the present study, we fabricated hierarchical copper- and zinc- buds dressing γ-AlOOH mesostrands (Cu- and Zn-AMSs) with randomly wrinkled morphology, mesoscale void- or cave-like pockets, high-exposed surface coverage sites, and positive charge streams in saline. We confirmed that Cu- and Zn-AMSs promoted intracellular uptake of model cancer antigen (ovalbumin, OVA) by THP-1-differentiated macrophage-like cells in vitro. Moreover, Cu- and Zn-AMSs enhanced maturation and cytokine release of bone marrow dendritic cells in vitro. In vivo study demonstrated that Cu- and Zn-AMSs markedly induced anti-tumor-immunity and enhanced CD(4) (+) and CD(8) (+) T cell populations in splenocytes of mice. These findings demonstrated that hierarchical copper- and zinc- buds dressing γ-AlOOH mesostrands, which are oriented in randomly wrinkled matrice, are suitable platforms as novel adjuvants for cancer immunotherapy. |
format | Online Article Text |
id | pubmed-5711866 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-57118662017-12-06 Hierarchically porous, and Cu- and Zn-containing γ-AlOOH mesostrands as adjuvants for cancer immunotherapy Li, Xia Shenashen, Mohamed A. Wang, Xiupeng Ito, Atsuo Taniguchi, Akiyoshi EI-Safty, Sherif A. Sci Rep Article Alum is the only licensed adjuvant by Food and Drug Administration of USA used in many human vaccines and has excellent safety record in clinical applications. However, alum hardly induces T helper 1 (Th1) immune responses that are required for anti-tumor immunity. In the present study, we fabricated hierarchical copper- and zinc- buds dressing γ-AlOOH mesostrands (Cu- and Zn-AMSs) with randomly wrinkled morphology, mesoscale void- or cave-like pockets, high-exposed surface coverage sites, and positive charge streams in saline. We confirmed that Cu- and Zn-AMSs promoted intracellular uptake of model cancer antigen (ovalbumin, OVA) by THP-1-differentiated macrophage-like cells in vitro. Moreover, Cu- and Zn-AMSs enhanced maturation and cytokine release of bone marrow dendritic cells in vitro. In vivo study demonstrated that Cu- and Zn-AMSs markedly induced anti-tumor-immunity and enhanced CD(4) (+) and CD(8) (+) T cell populations in splenocytes of mice. These findings demonstrated that hierarchical copper- and zinc- buds dressing γ-AlOOH mesostrands, which are oriented in randomly wrinkled matrice, are suitable platforms as novel adjuvants for cancer immunotherapy. Nature Publishing Group UK 2017-12-01 /pmc/articles/PMC5711866/ /pubmed/29196724 http://dx.doi.org/10.1038/s41598-017-12446-9 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Li, Xia Shenashen, Mohamed A. Wang, Xiupeng Ito, Atsuo Taniguchi, Akiyoshi EI-Safty, Sherif A. Hierarchically porous, and Cu- and Zn-containing γ-AlOOH mesostrands as adjuvants for cancer immunotherapy |
title | Hierarchically porous, and Cu- and Zn-containing γ-AlOOH mesostrands as adjuvants for cancer immunotherapy |
title_full | Hierarchically porous, and Cu- and Zn-containing γ-AlOOH mesostrands as adjuvants for cancer immunotherapy |
title_fullStr | Hierarchically porous, and Cu- and Zn-containing γ-AlOOH mesostrands as adjuvants for cancer immunotherapy |
title_full_unstemmed | Hierarchically porous, and Cu- and Zn-containing γ-AlOOH mesostrands as adjuvants for cancer immunotherapy |
title_short | Hierarchically porous, and Cu- and Zn-containing γ-AlOOH mesostrands as adjuvants for cancer immunotherapy |
title_sort | hierarchically porous, and cu- and zn-containing γ-alooh mesostrands as adjuvants for cancer immunotherapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711866/ https://www.ncbi.nlm.nih.gov/pubmed/29196724 http://dx.doi.org/10.1038/s41598-017-12446-9 |
work_keys_str_mv | AT lixia hierarchicallyporousandcuandzncontaininggaloohmesostrandsasadjuvantsforcancerimmunotherapy AT shenashenmohameda hierarchicallyporousandcuandzncontaininggaloohmesostrandsasadjuvantsforcancerimmunotherapy AT wangxiupeng hierarchicallyporousandcuandzncontaininggaloohmesostrandsasadjuvantsforcancerimmunotherapy AT itoatsuo hierarchicallyporousandcuandzncontaininggaloohmesostrandsasadjuvantsforcancerimmunotherapy AT taniguchiakiyoshi hierarchicallyporousandcuandzncontaininggaloohmesostrandsasadjuvantsforcancerimmunotherapy AT eisaftysherifa hierarchicallyporousandcuandzncontaininggaloohmesostrandsasadjuvantsforcancerimmunotherapy |